Andrei L.
- Country
- Romania
- Department
- Medical II
Research Overview
- Phase 3 Study of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma
- Efficacy, Safety, and Tolerability of Beclometasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide in COPD: A Randomized, Double-Blind Study
- Efficacy and Safety of SAR443765 in Adults with High-Risk Asthma Ineligible for Biologic Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Data & Insights
Has run more than one trial at 28 of 193 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in treating and studying major respiratory conditions, with particular emphasis on chronic obstructive pulmonary disease (COPD) and various forms of asthma.
- COPD Management
- Mild to Severe Asthma
- High-Risk Asthma Cases
Their research encompasses innovative therapeutic approaches for respiratory conditions using pressurized metered dose inhalers.
Therapeutic Applications
The investigator focuses on evaluating novel inhaler-based treatments and examining their effectiveness in improving lung function and reducing disease exacerbations.
- Inhaler Delivery Systems
- Pre-dose Lung Function Assessment
- Novel Propellant Technologies
Their work includes comparative studies of different inhaler propellants and delivery mechanisms for respiratory medications.
Clinical Focus Areas
The investigator's expertise extends to studying biological therapeutics and their applications in respiratory medicine.
- Exacerbation Prevention
- Lung Function Improvement
- Treatment Safety Evaluation
Their research encompasses both established treatments and emerging therapeutic approaches for respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.